Selenium and metabolic disorders: An emphasis on type 2 diabetes risk

Nutrients

Volumn 8, Issue 2, 2016, Pages

  Ogawa Wong, Ashley N ^a   Berry, Marla J ^a   Seale, Lucia A ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Metabolic disease; Selenium; Selenoproteins; Trace element

Indexed keywords

GLUTATHIONE PEROXIDASE 1; IODIDE PEROXIDASE; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; SELENIUM; SELENOPROTEIN; SELENOPROTEIN P; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE BLOOD LEVEL; TRACE ELEMENT;

ANTIOXIDANT ACTIVITY; BIOLOGICAL ACTIVITY; DIET SUPPLEMENTATION; ENERGY METABOLISM; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC POLYMORPHISM; GLUCOSE HOMEOSTASIS; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INSULIN RESISTANCE; LIPID METABOLISM; LIPID PEROXIDATION; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN SYNTHESIS; REVIEW; SELENIUM BLOOD LEVEL; SELENIUM DEFICIENCY; SEX DIFFERENCE; ADVERSE EFFECTS; BLOOD; DIABETES MELLITUS, TYPE 2; DIET; DIETARY SUPPLEMENT; FEMALE; FORTIFIED FOOD; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; NUTRITIONAL STATUS;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET; DIETARY SUPPLEMENTS; FEMALE; FOOD, FORTIFIED; HUMANS; MALE; METABOLIC DISEASES; NUTRITIONAL STATUS; SELENIUM; TRACE ELEMENTS;

EID: 84958052967     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8020080     Document Type: Review

References (138)

1. Kryukov, G.V.; Castellano, S.; Novoselov, S.V.; Lobanov, A.V.; Zehtab, O.; Guigó, R.; Gladyshev, V.N. Characterization of Mammalian Selenoproteomes. Science 2003, 300, 1439-1443. [CrossRef] [PubMed]
2. Keshan Disease Research Group. Observations on effect of sodium selenite in prevention of Keshan disease. Chin. Med. J. 1979, 92, 471-476.
3. Moreno-Reyes, R.; Egrise, D.; Nève, J.; Pasteels, J.L.; Schoutens, A. Selenium deficiency-induced growth retardation is associated with an impaired bone metabolism and osteopenia. J. Bone Miner. Res. 2001, 16, 1556-1563. [CrossRef] [PubMed]
4. Ahsan, U.; Kamran, Z.; Raza, I.; Ahmad, S.; Babar, W.; Riaz, M.H.; Iqbal, Z. Role of selenium in male reproduction - a review. Anim. Reprod. Sci. 2014, 146, 55-62. [CrossRef] [PubMed]
5. Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids; National Academies Press (US):Washington, DC, USA, 2000.
6. Ezaki, O. The insulin-like effects of selenate in rat adipocytes. J. Biol. Chem. 1990, 265, 1124-1128. [PubMed]
7. Akbaraly, T.N.; Arnaud, J.; Rayman, M.P.; Hininger-Favier, I.; Roussel, A.-M.; Berr, C.; Fontbonne, A. Plasma selenium and risk of dysglycemia in an elderly French population: results from the prospective Epidemiology of Vascular Ageing Study. Nutr. Metab. 2010, 7, 21. [CrossRef] [PubMed]
8. Navarro-Alarcón, M.; López-G de la Serrana, H.; Pérez-Valero, V.; López-Martínez, C. Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus. Sci. Total Environ. 1999, 228, 79-85. [CrossRef]
9. Park, K.; Rimm, E.B.; Siscovick, D.S.; Spiegelman, D.; Manson, J.E.; Morris, J.S.; Hu, F.B.; Mozaffarian, D. Toenail selenium and incidence of type 2 diabetes in U.S. men and women. Diabetes Care 2012, 35, 1544-1551. [CrossRef] [PubMed]
10. Bleys, J.; Navas-Acien, A.; Guallar, E. Serum Selenium and Diabetes in U.S. Adults. Diabetes Care 2007, 30, 829-834. [CrossRef] [PubMed]
11. Laclaustra, M.; Navas-Acien, A.; Stranges, S.; Ordovas, J.M.; Guallar, E. Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Environ. Health Perspect. 2009, 117, 1409-1413. [CrossRef] [PubMed]
12. Stranges, S.; Marshall, J.R.; Natarajan, R.; Donahue, R.P.; Trevisan, M.; Combs, G.F.; Cappuccio, F.P.; Ceriello, A.; Reid, M.E. Effects of Long-Term Selenium Supplementation on the Incidence of Type 2 Diabetes: A Randomized Trial. Ann. Intern. Med. 2007, 147, 217-223. [CrossRef] [PubMed]
13. Lippman, S.M.; Klein, E.A.; Goodman, P.J.; Lucia, M.S.; Thompson, I.M.; Ford, L.G.; Parnes, H.L.; Minasian, L.M.; Gaziano, J.M.; Hartline, J.A., et al. Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009, 301, 39. [CrossRef] [PubMed]
14. Klein, E.A.; Thompson, I.M.; Tangen, C.M.; Crowley, J.J.; Lucia, M.S.; Goodman, P.J.; Minasian, L.M.; Ford, L.G.; Parnes, H.L.; Gaziano, J.M., et al. Vitamin E and the risk of prostate cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011, 306, 1549-1556. [CrossRef] [PubMed]
15. Rayman, M.P.; Stranges, S. Epidemiology of selenium and type 2 diabetes: Can we make sense of it? Free Radic. Biol. Med. 2013, 65, 1557-1564. [CrossRef] [PubMed]
16. Rayman, M.P.; Blundell-Pound, G.; Pastor-Barriuso, R.; Guallar, E.; Steinbrenner, H.; Stranges, S. A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin. PLoS ONE 2012, 7, e45269. [CrossRef] [PubMed]
17. Mao, J.; Bath, S.C.; Vanderlelie, J.J.; Perkins, A.V.; Redman, C.W.G.; Rayman, M.P. No effect of modest selenium supplementation on insulin resistance in UK pregnant women, as assessed by plasma adiponectin concentration. Br. J. Nutr. 2016, 115, 32-38. [CrossRef] [PubMed]
18. Hintze, K.J.; Lardy, G.P.; Marchello, M.J.; Finley, J.W. Selenium accumulation in beef: Effect of dietary selenium and geographical area of animal origin. J. Agric. Food Chem. 2002, 50, 3938-3942. [CrossRef] [PubMed]
19. Combs, G.F. Selenium in global food systems. Br. J. Nutr. 2001, 85, 517-547. [CrossRef] [PubMed]
20. Rayman, M.P. Selenium and human health. Lancet 2012, 379, 1256-1268. [CrossRef]
21. Winkel, L.H.E.; Vriens, B.; Jones, G.D.; Schneider, L.S.; Pilon-Smits, E.; Bañuelos, G.S. Selenium cycling across soil-plant-atmosphere interfaces: a critical review. Nutrients 2015, 7, 4199-4239. [CrossRef] [PubMed]
22. Sors, T.G.; Ellis, D.R.; Salt, D.E. Selenium uptake, translocation, assimilation and metabolic fate in plants. Photosynth. Res. 2005, 86, 373-389. [CrossRef] [PubMed]
23. Burk, R.F.; Hill, K.E. Regulation of Selenium Metabolism and Transport. Annu. Rev. Nutr. 2015, 35, 109-134. [CrossRef] [PubMed]
24. Wilber, C.G. Toxicology of selenium: A review. Clin. Toxicol. 1980, 17, 171-230. [CrossRef] [PubMed]
25. Rayman, M.P. Food-chain selenium and human health: Emphasis on intake. Br. J. Nutr. 2008, 100, 254-268. [CrossRef] [PubMed]
26. Speckmann, B.; Grune, T. Epigenetic effects of selenium and their implications for health. Epigenetics 2015, 10, 179-190. [CrossRef] [PubMed]
27. Wastney, M.E.; Combs, G.F.; Canfield, W.K.; Taylor, P.R.; Patterson, K.Y.; Hill, A.D.; Moler, J.E.; Patterson, B.H. A human model of selenium that integrates metabolism from selenite and selenomethionine. J. Nutr. 2011, 141, 708-717. [CrossRef] [PubMed]
28. Thiry, C.; Ruttens, A.; Pussemier, L.; Schneider, Y.-J. An in vitro investigation of species-dependent intestinal transport of selenium and the impact of this process on selenium bioavailability. Br. J. Nutr. 2013, 109, 2126-2134. [CrossRef] [PubMed]
29. Fairweather-Tait, S.J.; Bao, Y.; Broadley, M.R.; Collings, R.; Ford, D.; Hesketh, J.E.; Hurst, R. Selenium in human health and disease. Antioxid. Redox Signal. 2011, 14, 1337-1383. [CrossRef] [PubMed]
30. Van Dael, P.; Davidsson, L.; Ziegler, E.E.; Fay, L.B.; Barclay, D. Comparison of selenite and selenate apparent absorption and retention in infants using stable isotope methodology. Pediatr. Res. 2002, 51, 71-75. [CrossRef] [PubMed]
31. Wolffram, S.; Ardüser, F.; Scharrer, E. In vivo intestinal absorption of selenate and selenite by rats. J. Nutr. 1985, 115, 454-459. [PubMed]
32. Finley, J.W.; Duffield, A.; Ha, P.; Vanderpool, R.A.; Thomson, C.D. Selenium supplementation affects the retention of stable isotopes of selenium in human subjects consuming diets low in selenium. Br. J. Nutr. 1999, 82, 357-360. [PubMed]
33. Swanson, C.A.; Patterson, B.H.; Levander, O.A.; Veillon, C.; Taylor, P.R.; Helzlsouer, K.; McAdam, P.A.; Zech, L.A. Human [74Se]selenomethionine metabolism: A kinetic model. Am. J. Clin. Nutr. 1991, 54, 917-926. [PubMed]
34. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific opinion on dietary reference values for selenium. EFSA J. 2014, 12, 3846.
35. Kobayashi, Y.; Ogra, Y.; Ishiwata, K.; Takayama, H.; Aimi, N.; Suzuki, K.T. Selenosugars are key and urinary metabolites for selenium excretion within the required to low-toxic range. Proc. Natl. Acad. Sci. USA 2002, 99, 15932-15936. [CrossRef] [PubMed]
36. Thomson, C.D. Assessment of requirements for selenium and adequacy of selenium status: A review. Eur. J. Clin. Nutr. 2004, 58, 391-402. [CrossRef] [PubMed]
37. Burk, R.F. Molecular biology of selenium with implications for its metabolism. FASEB J. 1991, 5, 2274-2279. [PubMed]
38. Esaki, N.; Nakamura, T.; Tanaka, H.; Suzuki, T.; Morino, Y.; Soda, K. Enzymatic synthesis of selenocysteine in rat liver. Biochemistry 1981, 20, 4492-4496. [CrossRef] [PubMed]
39. Okuno, T.; Motobayashi, S.; Ueno, H.; Nakamuro, K. Identification of mouse selenomethionine alpha,gamma-elimination enzyme: Cystathionine gamma-lyase catalyzes its reaction to generate methylselenol. Biol. Trace Elem. Res. 2005, 108, 245-257. [CrossRef]
40. Okuno, T.; Motobayashi, S.; Ueno, H.; Nakamuro, K. Purification and characterization of mouse hepatic enzyme that converts selenomethionine to methylselenol by its alpha,gamma-elimination. Biol. Trace Elem. Res. 2005, 106, 77-94. [CrossRef]
41. Singh, S.; Banerjee, R. PLP-dependent H(2)S biogenesis. Biochim. Biophys. Acta 2011, 1814, 1518-1527. [CrossRef] [PubMed]
42. Okuno, T.; Ueno, H.; Nakamuro, K. Cystathionine gamma-lyase contributes to selenomethionine detoxification and cytosolic glutathione peroxidase biosynthesis in mouse liver. Biol. Trace Elem. Res. 2006, 109, 155-171. [CrossRef]
43. Xu, X.-M.; Turanov, A.A.; Carlson, B.A.; Yoo, M.-H.; Everley, R.A.; Nandakumar, R.; Sorokina, I.; Gygi, S.P.; Gladyshev, V.N.; Hatfield, D.L. Targeted insertion of cysteine by decoding UGA codons with mammalian selenocysteine machinery. Proc. Natl. Acad. Sci. USA 2010, 107, 21430-21434. [CrossRef] [PubMed]
44. Lee, B.J.; Worland, P.J.; Davis, J.N.; Stadtman, T.C.; Hatfield, D.L. Identification of a selenocysteyl-tRNA(Ser) in mammalian cells that recognizes the nonsense codon, UGA. J. Biol. Chem. 1989, 264, 9724-9727. [PubMed]
45. Carlson, B.A.; Xu, X.-M.; Kryukov, G.V.; Rao, M.; Berry, M.J.; Gladyshev, V.N.; Hatfield, D.L. Identification and characterization of phosphoseryl-tRNA[Ser]Sec kinase. Proc. Natl. Acad. Sci. USA 2004, 101, 12848-12853. [CrossRef] [PubMed]
46. Xu, X.-M.; Carlson, B.A.; Irons, R.; Mix, H.; Zhong, N.; Gladyshev, V.N.; Hatfield, D.L. Selenophosphate synthetase 2 is essential for selenoprotein biosynthesis. Biochem. J. 2007, 404, 115-120. [CrossRef] [PubMed]
47. Xu, X.-M.; Carlson, B.A.; Mix, H.; Zhang, Y.; Saira, K.; Glass, R.S.; Berry, M.J.; Gladyshev, V.N.; Hatfield, D.L. Biosynthesis of selenocysteine on its tRNA in eukaryotes. PLoS Biol. 2006, 5, e4. [CrossRef] [PubMed]
48. Mizutani, T.; Kanaya, K.; Tanabe, K. Selenophosphate as a substrate for mammalian selenocysteine synthase, its stability and toxicity. BioFactors 1999, 9, 27-36. [CrossRef] [PubMed]
49. Berry, M.J.; Banu, L.; Chen, Y.Y.; Mandel, S.J.; Kieffer, J.D.; Harney, J.W.; Larsen, P.R. Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 31 untranslated region. Nature 1991, 353, 273-276. [CrossRef] [PubMed]
50. Copeland, P.R.; Fletcher, J.E.; Carlson, B.A.; Hatfield, D.L.; Driscoll, D.M. A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs. EMBO J. 2000, 19, 306-314. [CrossRef] [PubMed]
51. Copeland, P.R.; Stepanik, V.A.; Driscoll, D.M. Insight into mammalian selenocysteine insertion: Domain structure and ribosome binding properties of Sec insertion sequence binding protein 2. Mol. Cell. Biol. 2001, 21, 1491-1498. [CrossRef] [PubMed]
52. Fagegaltier, D.; Hubert, N.; Yamada, K.; Mizutani, T.; Carbon, P.; Krol, A. Characterization of mSelB, a novel mammalian elongation factor for selenoprotein translation. EMBO J. 2000, 19, 4796-4805. [CrossRef] [PubMed]
53. Tujebajeva, R.M.; Copeland, P.R.; Xu, X.M.; Carlson, B.A.; Harney, J.W.; Driscoll, D.M.; Hatfield, D.L.; Berry, M.J. Decoding apparatus for eukaryotic selenocysteine insertion. EMBO Rep. 2000, 1, 158-163. [CrossRef] [PubMed]
54. Bifano, A.L.; Atassi, T.; Ferrara, T.; Driscoll, D.M. Identification of nucleotides and amino acids that mediate the interaction between ribosomal protein L30 and the SECIS element. BMC Mol. Biol. 2013, 14, 12. [CrossRef] [PubMed]
55. Chavatte, L.; Brown, B.A.; Driscoll, D.M. Ribosomal protein L30 is a component of the UGA-selenocysteine recoding machinery in eukaryotes. Nat. Struct. Mol. Biol. 2005, 12, 408-416. [CrossRef] [PubMed]
56. Small-Howard, A.; Morozova, N.; Stoytcheva, Z.; Forry, E.P.; Mansell, J.B.; Harney, J.W.; Carlson, B.A.; Xu, X.; Hatfield, D.L.; Berry, M.J. Supramolecular Complexes Mediate Selenocysteine Incorporation In Vivo. Mol. Cell. Biol. 2006, 26, 2337-2346. [CrossRef] [PubMed]
57. Xu, X.-M.; Mix, H.; Carlson, B.A.; Grabowski, P.J.; Gladyshev, V.N.; Berry, M.J.; Hatfield, D.L. Evidence for direct roles of two additional factors, SECp43 and soluble liver antigen, in the selenoprotein synthesis machinery. J. Biol. Chem. 2005, 280, 41568-41575. [CrossRef] [PubMed]
58. Howard, M.T.; Carlson, B.A.; Anderson, C.B.; Hatfield, D.L. Translational redefinition of UGA codons is regulated by selenium availability. J. Biol. Chem. 2013, 288, 19401-19413. [CrossRef] [PubMed]
59. Seyedali, A.; Berry, M.J. Nonsense-mediated decay factors are involved in the regulation of selenoprotein mRNA levels during selenium deficiency. RNA 2014, 20, 1248-1256. [CrossRef] [PubMed]
60. Esaki, N.; Nakamura, T.; Tanaka, H.; Soda, K. Selenocysteine lyase, a novel enzyme that specifically acts on selenocysteine. Mammalian distribution and purification and properties of pig liver enzyme. J. Biol. Chem. 1982, 257, 4386-4391. [PubMed]
61. Omi, R.; Kurokawa, S.; Mihara, H.; Hayashi, H.; Goto, M.; Miyahara, I.; Kurihara, T.; Hirotsu, K.; Esaki, N. Reaction Mechanism and Molecular Basis for Selenium/Sulfur Discrimination of Selenocysteine Lyase. J. Biol. Chem. 2010, 285, 12133-12139. [CrossRef] [PubMed]
62. Kurokawa, S.; Takehashi, M.; Tanaka, H.; Mihara, H.; Kurihara, T.; Tanaka, S.; Hill, K.; Burk, R.; Esaki, N. Mammalian Selenocysteine Lyase Is Involved in Selenoprotein Biosynthesis. J. Nutr. Sci. Vitaminol. 2011, 57, 298-305. [CrossRef] [PubMed]
63. Tobe, R.; Mihara, H.; Kurihara, T.; Esaki, N. Identification of proteins interacting with selenocysteine lyase. Biosci. Biotechnol. Biochem. 2009, 73, 1230-1232. [CrossRef] [PubMed]
64. Byrns, C.N.; Pitts, M.W.; Gilman, C.A.; Hashimoto, A.C.; Berry, M.J. Mice Lacking Selenoprotein P and Selenocysteine Lyase Exhibit Severe Neurological Dysfunction, Neurodegeneration, and Audiogenic Seizures. J. Biol. Chem. 2014, 289, 9662-9674. [CrossRef] [PubMed]
65. Labunskyy, V.M.; Lee, B.C.; Handy, D.E.; Loscalzo, J.; Hatfield, D.L.; Gladyshev, V.N. Both Maximal Expression of Selenoproteins and Selenoprotein Deficiency Can Promote Development of Type 2 Diabetes- Like Phenotype in Mice. Antioxid. Redox Signal. 2011, 14, 2327-2336. [CrossRef] [PubMed]
66. Wang, X.; Zhang, W.; Chen, H.; Liao, N.; Wang, Z.; Zhang, X.; Hai, C. High selenium impairs hepatic insulin sensitivity through opposite regulation of ROS. Toxicol. Lett. 2014, 224, 16-23. [CrossRef] [PubMed]
67. Pinto, A.; Juniper, D.T.; Sanil, M.; Morgan, L.; Clark, L.; Sies, H.; Rayman, M.P.; Steinbrenner, H. Supranutritional selenium induces alterations in molecular targets related to energy metabolism in skeletal muscle and visceral adipose tissue of pigs. J. Inorg. Biochem. 2012, 114, 47-54. [CrossRef] [PubMed]
68. Campbell, S.C.; Aldibbiat, A.; Marriott, C.E.; Landy, C.; Ali, T.; Ferris, W.F.; Butler, C.S.; Shaw, J.A.; Macfarlane, W.M. Selenium stimulates pancreatic beta-cell gene expression and enhances islet function. FEBS Lett. 2008, 582, 2333-2337. [CrossRef] [PubMed]
69. Steinbrenner, H.; Hotze, A.-L.; Speckmann, B.; Pinto, A.; Sies, H.; Schott, M.; Ehlers, M.; Scherbaum, W.A.; Schinner, S. Localization and regulation of pancreatic selenoprotein P. J. Mol. Endocrinol. 2013, 50, 31-42. [CrossRef] [PubMed]
70. Esser, N.; Legrand-Poels, S.; Piette, J.; Scheen, A.J.; Paquot, N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract. 2014, 105, 141-150. [CrossRef] [PubMed]
71. Duntas, L.H. Selenium and inflammation: Underlying anti-inflammatory mechanisms. Horm. Metab. Res. 2009, 41, 443-447. [CrossRef] [PubMed]
72. Kretz-Remy, C.; Arrigo, A.-P. Selenium: A key element that controls NF-κB activation and IκBα. Biofactors 2001, 14, 117. [CrossRef] [PubMed]
73. Zhang, W.; Zhang, R.; Wang, T.; Jiang, H.; Guo, M.; Zhou, E.; Sun, Y.; Yang, Z.; Xu, S.; Cao, Y., et al. Selenium inhibits LPS-induced pro-inflammatory gene expression by modulating MAPK and NF-κB signaling pathways in mouse mammary epithelial cells in primary culture. Inflammation 2014, 37, 478-485. [CrossRef] [PubMed]
74. Pillai, S.S.; Sugathan, J.K.; Indira, M. Selenium downregulates RAGE and NFκB expression in diabetic rats. Biol. Trace Elem. Res. 2012, 149, 71-77. [CrossRef] [PubMed]
75. Zeng, J.; Zhou, J.; Huang, K. Effect of selenium on pancreatic proinflammatory cytokines in streptozotocin-induced diabetic mice. J. Nutr. Biochem. 2009, 20, 530-536. [CrossRef] [PubMed]
76. McClung, J.P.; Roneker, C.A.; Mu, W.; Lisk, D.J.; Langlais, P.; Liu, F.; Lei, X.G. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc. Natl. Acad. Sci. USA 2004, 101, 8852-8857. [CrossRef] [PubMed]
77. Wang, X.D.; Vatamaniuk, M.Z.; Wang, S.K.; Roneker, C.A.; Simmons, R.A.; Lei, X.G. Molecular mechanisms for hyperinsulinaemia induced by overproduction of selenium-dependent glutathione peroxidase-1 in mice. Diabetologia 2008, 51, 1515-1524. [CrossRef] [PubMed]
78. Loh, K.; Deng, H.; Fukushima, A.; Cai, X.; Boivin, B.; Galic, S.; Bruce, C.; Shields, B.J.; Skiba, B.; Ooms, L.M., et al. Reactive oxygen species enhance insulin sensitivity. Cell Metab. 2009, 10, 260-272. [CrossRef] [PubMed]
79. Tanaka, Y.; Tran, P.O.T.; Harmon, J.; Robertson, R.P. A role for glutathione peroxidase in protecting pancreatic beta cells against oxidative stress in a model of glucose toxicity. Proc. Natl. Acad. Sci. USA 2002, 99, 12363-12368. [CrossRef] [PubMed]
80. Merry, T.L.; Tran, M.; Stathopoulos, M.; Wiede, F.; Fam, B.C.; Dodd, G.T.; Clarke, I.; Watt, M.J.; Andrikopoulos, S.; Tiganis, T. High-fat-fed obese glutathione peroxidase 1-deficient mice exhibit defective insulin secretion but protection from hepatic steatosis and liver damage. Antioxid. Redox Signal. 2014, 20, 2114-2129. [CrossRef] [PubMed]
81. Gurzov, E.N.; Tran, M.; Fernandez-Rojo, M.A.; Merry, T.L.; Zhang, X.; Xu, Y.; Fukushima, A.; Waters, M.J.; Watt, M.J.; Andrikopoulos, S., et al. Hepatic oxidative stress promotes insulin-STAT-5 signaling and obesity by inactivating protein tyrosine phosphatase N2. Cell Metab. 2014, 20, 85-102. [CrossRef] [PubMed]
82. Wang, X.; Yun, J.-W.; Lei, X.G. Glutathione peroxidase mimic ebselen improves glucose-stimulated insulin secretion in murine islets. Antioxid. Redox Signal. 2014, 20, 191-203. [CrossRef] [PubMed]
83. Tersey, S.A.; Maier, B.; Nishiki, Y.; Maganti, A.V.; Nadler, J.L.; Mirmira, R.G. 12-lipoxygenase promotes obesity-induced oxidative stress in pancreatic islets. Mol. Cell. Biol. 2014, 34, 3735-3745. [CrossRef] [PubMed]
84. Kuzuya, M.; Ando, F.; Iguchi, A.; Shimokata, H. Glutathione peroxidase 1 Pro198Leu variant contributes to the metabolic syndrome in men in a large Japanese cohort. Am. J. Clin. Nutr. 2008, 87, 1939-1944. [PubMed]
85. Misu, H.; Takamura, T.; Takayama, H.; Hayashi, H.; Matsuzawa-Nagata, N.; Kurita, S.; Ishikura, K.; Ando, H.; Takeshita, Y.; Ota, T., et al. A Liver-Derived Secretory Protein, Selenoprotein P, Causes Insulin Resistance. Cell Metab. 2010, 12, 483-495. [CrossRef] [PubMed]
86. Hurst, R.; Armah, C.N.; Dainty, J.R.; Hart, D.J.; Teucher, B.; Goldson, A.J.; Broadley, M.R.; Motley, A.K.; Fairweather-Tait, S.J. Establishing optimal selenium status: Results of a randomized, double-blind, placebo-controlled trial. Am. J. Clin. Nutr. 2010, 91, 923-931. [CrossRef] [PubMed]
87. Caselli, C. Role of adiponectin system in insulin resistance. Mol. Genet. Metab. 2014, 113, 155-160. [CrossRef] [PubMed]
88. Misu, H.; Ishikura, K.; Kurita, S.; Takeshita, Y.; Ota, T.; Saito, Y.; Takahashi, K.; Kaneko, S.; Takamura, T. Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes. PLoS ONE 2012, 7, e34952. [CrossRef] [PubMed]
89. Yang, S.J.; Hwang, S.Y.; Choi, H.Y.; Yoo, H.J.; Seo, J.A.; Kim, S.G.; Kim, N.H.; Baik, S.H.; Choi, D.S.; Choi, K.M. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: Implications for insulin resistance, inflammation, and atherosclerosis. J. Clin. Endocrinol. Metab. 2011, 96, E1325-E1329. [CrossRef] [PubMed]
90. Hellwege, J.N.; Palmer, N.D.; Ziegler, J.T.; Langefeld, C.D.; Lorenzo, C.; Norris, J.M.; Takamura, T.; Bowden, D.W. Genetic variants in selenoprotein P plasma 1 gene (SEPP1) are associated with fasting insulin and first phase insulin response in Hispanics. Gene 2014, 534, 33-39. [CrossRef] [PubMed]
91. Speckmann, B.; Walter, P.L.; Alili, L.; Reinehr, R.; Sies, H.; Klotz, L.-O.; Steinbrenner, H. Selenoprotein P expression is controlled through interaction of the coactivator PGC-1alpha with FoxO1a and hepatocyte nuclear factor 4alpha transcription factors. Hepatology 2008, 48, 1998-2006. [CrossRef] [PubMed]
92. peckmann, B.; Sies, H.; Steinbrenner, H. Attenuation of hepatic expression and secretion of selenoprotein P by metformin. Biochem. Biophys. Res. Commun. 2009, 387, 158-163. [CrossRef] [PubMed]
93. Takayama, H.; Misu, H.; Iwama, H.; Chikamoto, K.; Saito, Y.; Murao, K.; Teraguchi, A.; Lan, F.; Kikuchi, A.; Saito, R., et al. Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)/FoxO3a pathway in H4IIEC3 hepatocytes. J. Biol. Chem. 2014, 289, 335-345. [CrossRef] [PubMed]
94. Ferguson, A.D.; Labunskyy, V.M.; Fomenko, D.E.; Araç, D.; Chelliah, Y.; Amezcua, C.A.; Rizo, J.; Gladyshev, V.N.; Deisenhofer, J. NMR structures of the selenoproteins Sep15 and SelM reveal redox activity of a new thioredoxin-like family. J. Biol. Chem. 2006, 281, 3536-3543. [CrossRef] [PubMed]
95. Reeves, M.A.; Bellinger, F.P.; Berry, M.J. The Neuroprotective Functions of Selenoprotein M and its Role in Cytosolic Calcium Regulation. Antioxid. Redox Signal. 2010, 12, 809-818. [CrossRef] [PubMed]
96. Pitts, M.W.; Reeves, M.A.; Hashimoto, A.C.; Ogawa, A.; Kremer, P.; Seale, L.A.; Berry, M.J. Deletion of Selenoprotein M Leads to Obesity without Cognitive Deficits. J. Biol. Chem. 2013, 288, 26121-26134. [CrossRef] [PubMed]
97. Ozcan, L.; Ergin, A.S.; Lu, A.; Chung, J.; Sarkar, S.; Nie, D.; Myers Jr., M.G.; Ozcan, U. Endoplasmic Reticulum Stress Plays a Central Role in Development of Leptin Resistance. Cell Metab. 2009, 9, 35-51. [CrossRef] [PubMed]
98. Berry, M.J.; Larsen, P.R. The role of selenium in thyroid hormone action. Endocr. Rev. 1992, 13, 207-219. [PubMed]
99. Schomburg, L. Selenium, selenoproteins and the thyroid gland: Interactions in health and disease. Nat. Rev. Endocrinol. 2011, 8, 160-171. [CrossRef] [PubMed]
100. Larson, P.R.; Ingbar, S.H. The Thyroid Gland. In Williams Textbook of Endocrinology; Wilson, J.D., Foster, D.W., Eds.; W.B. Saunders Company: Philadelphia, PA, USA, 1992; pp. 357-487.
101. Marsili, A.; Zavacki, A.M.; Harney, J.W.; Larsen, P.R. Physiological role and regulation of iodothyronine deiodinases: A 2011 update. J. Endocrinol. Investig. 2011, 34, 395-407. [CrossRef] [PubMed]
102. Mullur, R.; Liu, Y.-Y.; Brent, G.A. Thyroid hormone regulation of metabolism. Physiol. Rev. 2014, 94, 355-382. [CrossRef] [PubMed]
103. Vernia, S.; Cavanagh-Kyros, J.; Barrett, T.; Jung, D.Y.; Kim, J.K.; Davis, R.J. Diet-induced obesity mediated by the JNK/DIO2 signal transduction pathway. Genes Dev. 2013, 27, 2345-2355. [CrossRef] [PubMed]
104. Fonseca, T.L.; Correa-Medina, M.; Campos, M.P.O.; Wittmann, G.; Werneck-de-Castro, J.P.; Arrojo e Drigo, R.; Mora-Garzon, M.; Ueta, C.B.; Caicedo, A.; Fekete, C., et al. Coordination of hypothalamic and pituitary T3 production regulates TSH expression. J. Clin. Investig. 2013, 123, 1492-1500. [CrossRef] [PubMed]
105. De Jesus, L.A.; Carvalho, S.D.; Ribeiro, M.O.; Schneider, M.; Kim, S.-W.; Harney, J.W.; Larsen, P.R.; Bianco, A.C. The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J. Clin. Investig. 2001, 108, 1379-1385. [CrossRef] [PubMed]
106. Christoffolete, M.A.; Linardi, C.C.G.; de Jesus, L.; Ebina, K.N.; Carvalho, S.D.; Ribeiro, M.O.; Rabelo, R.; Curcio, C.; Martins, L.; Kimura, E.T., et al. Mice with Targeted Disruption of the Dio2 Gene Have Cold-Induced Overexpression of the Uncoupling Protein 1 Gene but Fail to Increase Brown Adipose Tissue Lipogenesis and Adaptive Thermogenesis. Diabetes 2004, 53, 577-584. [CrossRef] [PubMed]
107. Watanabe, M.; Houten, S.M.; Mataki, C.; Christoffolete, M.A.; Kim, B.W.; Sato, H.; Messaddeq, N.; Harney, J.W.; Ezaki, O.; Kodama, T., et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006, 439, 484-489. [CrossRef] [PubMed]
108. Marsili, A.; Aguayo-Mazzucato, C.; Chen, T.; Kumar, A.; Chung, M.; Lunsford, E.P.; Harney, J.W.; Van-Tran, T.; Gianetti, E.; Ramadan, W., et al. Mice with a Targeted Deletion of the Type 2 Deiodinase Are Insulin Resistant and Susceptible to Diet Induced Obesity. PLoS ONE 2011, 6, e20832. [CrossRef] [PubMed]
109. Coppola, A.; Liu, Z.-W.; Andrews, Z.B.; Paradis, E.; Roy, M.-C.; Friedman, J.M.; Ricquier, D.; Richard, D.; Horvath, T.L.; Gao, X.-B., et al. A central thermogenic-like mechanism in feeding regulation: An interplay between arcuate nucleus T3 and UCP2. Cell Metab. 2007, 5, 21-33. [CrossRef] [PubMed]
110. Kong, W.M.; Martin, N.M.; Smith, K.L.; Gardiner, J.V.; Connoley, I.P.; Stephens, D.A.; Dhillo, W.S.; Ghatei, M.A.; Small, C.J.; Bloom, S.R. Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditure. Endocrinology 2004, 145, 5252-5258. [CrossRef] [PubMed]
111. Christoffolete, M.A.; Doleschall, M.; Egri, P.; Liposits, Z.; Zavacki, A.M.; Bianco, A.C.; Gereben, B. Regulation of thyroid hormone activation via the liver X-receptor/retinoid X-receptor pathway. J. Endocrinol. 2010, 205, 179-186. [CrossRef] [PubMed]
112. Kalaany, N.Y.; Gauthier, K.C.; Zavacki, A.M.; Mammen, P.P.A.; Kitazume, T.; Peterson, J.A.; Horton, J.D.; Garry, D.J.; Bianco, A.C.; Mangelsdorf, D.J. LXRs regulate the balance between fat storage and oxidation. Cell Metab. 2005, 1, 231-244. [CrossRef] [PubMed]
113. Kryukov, G.V.; Kryukov, V.M.; Gladyshev, V.N. New mammalian selenocysteine-containing proteins identified with an algorithm that searches for selenocysteine insertion sequence elements. J. Biol. Chem. 1999, 274, 33888-33897. [CrossRef] [PubMed]
114. Dikiy, A.; Novoselov, S.V.; Fomenko, D.E.; Sengupta, A.; Carlson, B.A.; Cerny, R.L.; Ginalski, K.; Grishin, N. V.; Hatfield, D.L.; Gladyshev, V.N. SelT, SelW, SelH, and Rdx12: Genomics and molecular insights into the functions of selenoproteins of a novel thioredoxin-like family. Biochemistry 2007, 46, 6871-6882. [CrossRef] [PubMed]
115. Moustafa, M.E.; Antar, H.A. A bioinformatics approach to characterize mammalian selenoprotein T. Biochem. Genet. 2012, 50, 736-747. [CrossRef] [PubMed]
116. Tanguy, Y.; Falluel-Morel, A.; Arthaud, S.; Boukhzar, L.; Manecka, D.-L.; Chagraoui, A.; Prevost, G.; Elias, S.; Dorval-Coiffec, I.; Lesage, J., et al. The PACAP-Regulated Gene Selenoprotein T Is Highly Induced in Nervous, Endocrine, and Metabolic Tissues during Ontogenetic and Regenerative Processes. Endocrinology 2011, 152, 4322-4335. [CrossRef] [PubMed]
117. Grumolato, L.; Ghzili, H.; Montero-Hadjadje, M.; Gasman, S.; Lesage, J.; Tanguy, Y.; Galas, L.; Ait-Ali, D.; Leprince, J.; Guérineau, N.C., et al. Selenoprotein T is a PACAP-regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion. FASEB J. 2008, 22, 1756-1768. [CrossRef] [PubMed]
118. Dhillon, S.S.; McFadden, S.A.; Chalmers, J.A.; Centeno, M.-L.; Kim, G.L.; Belsham, D.D. Cellular leptin resistance impairs the leptin-mediated suppression of neuropeptide Y secretion in hypothalamic neurons. Endocrinology 2011, 152, 4138-4147. [CrossRef] [PubMed]
119. Chalmers, J.A.; Jang, J.J.; Belsham, D.D. Glucose sensing mechanisms in hypothalamic cell models: glucose inhibition of AgRP synthesis and secretion. Mol. Cell. Endocrinol. 2014, 382, 262-270. [CrossRef] [PubMed]
120. Nazarians-Armavil, A.; Chalmers, J.A.; Lee, C.B.; Ye, W.; Belsham, D.D. Cellular insulin resistance disrupts hypothalamic mHypoA-POMC/GFP neuronal signaling pathways. J. Endocrinol. 2014, 220, 13-24. [CrossRef] [PubMed]
121. Prevost, G.; Arabo, A.; Jian, L.; Quelennec, E.; Cartier, D.; Hassan, S.; Falluel-Morel, A.; Tanguy, Y.; Gargani, S.; Lihrmann, I., et al. The PACAP-regulated gene selenoprotein T is abundantly expressed in mouse and human β-cells and its targeted inactivation impairs glucose tolerance. Endocrinology 2013, 154, 3796-3806. [CrossRef] [PubMed]
122. Ye, Y.; Shibata, Y.; Yun, C.; Ron, D.; Rapoport, T.A. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 2004, 429, 841-847. [CrossRef] [PubMed]
123. Gao, Y.; Hannan, N.R.F.; Wanyonyi, S.; Konstantopolous, N.; Pagnon, J.; Feng, H.C.; Jowett, J.B.M.; Kim, K.-H.; Walder, K.; Collier, G.R. Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells. Cytokine 2006, 33, 246-251. [CrossRef] [PubMed]
124. Turanov, A.A.; Shchedrina, V.A.; Everley, R.A.; Lobanov, A.V.; Yim, S.H.; Marino, S.M.; Gygi, S.P.; Hatfield, D.L.; Gladyshev, V.N. Selenoprotein S is involved in maintenance and transport of multiprotein complexes. Biochem. J. 2014, 462, 555-565. [CrossRef] [PubMed]
125. Walder, K.; Kantham, L.; McMillan, J.S.; Trevaskis, J.; Kerr, L.; De Silva, A.; Sunderland, T.; Godde, N.; Gao, Y.; Bishara, N., et al. Tanis: A link between type 2 diabetes and inflammation? Diabetes 2002, 51, 1859-1866. [CrossRef] [PubMed]
126. Karlsson, H.K.R.; Tsuchida, H.; Lake, S.; Koistinen, H.A.; Krook, A. Relationship between serum amyloid A level and Tanis/SelS mRNA expression in skeletal muscle and adipose tissue from healthy and type 2 diabetic subjects. Diabetes 2004, 53, 1424-1428. [CrossRef] [PubMed]
127. Olsson, M.; Olsson, B.; Jacobson, P.; Thelle, D.S.; Björkegren, J.; Walley, A.; Froguel, P.; Carlsson, L.M.S.; Sjöholm, K. Expression of the selenoprotein S (SELS) gene in subcutaneous adipose tissue and SELS genotype are associated with metabolic risk factors. Metabolism 2011, 60, 114-120. [CrossRef] [PubMed]
128. Gao, Y.; Feng, H.C.; Walder, K.; Bolton, K.; Sunderland, T.; Bishara, N.; Quick, M.; Kantham, L.; Collier, G.R. Regulation of the selenoprotein SelS by glucose deprivation and endoplasmic reticulum stress—SelS is a novel glucose-regulated protein. FEBS Lett. 2004, 563, 185-190. [CrossRef]
129. Seale, L.A.; Hashimoto, A.C.; Kurokawa, S.; Gilman, C.L.; Seyedali, A.; Bellinger, F.P.; Raman, A.V.; Berry, M.J. Disruption of the Selenocysteine Lyase-Mediated Selenium Recycling Pathway Leads to Metabolic Syndrome in Mice. Mol. Cell. Biol. 2012, 32, 4141-4154. [CrossRef] [PubMed]
130. Seale, L.A.; Gilman, C.L.; Hashimoto, A.C.; Ogawa-Wong, A.N.; Berry, M.J. Diet-Induced Obesity in the Selenocysteine Lyase Knockout Mouse. Antioxid. Redox Signal. 2015, 23, 761-774. [CrossRef] [PubMed]
131. Schomburg, L.; Schweizer, U. Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium. Biochim. Biophys. Acta 2009, 1790, 1453-1462. [CrossRef] [PubMed]
132. Stoedter, M.; Renko, K.; Hög, A.; Schomburg, L. Selenium controls the sex-specific immune response and selenoprotein expression during the acute-phase response in mice. Biochem. J. 2010, 429, 43-51. [CrossRef] [PubMed]
133. Burk, R.F.; Hill, K.E.; Olson, G.E.; Weeber, E.J.; Motley, A.K.; Winfrey, V.P.; Austin, L.M. Deletion of Apolipoprotein E Receptor-2 in Mice Lowers Brain Selenium and Causes Severe Neurological Dysfunction and Death When a Low-Selenium Diet Is Fed. J. Neurosci. 2007, 27, 6207-6211. [CrossRef] [PubMed]
134. Olson, G.E.; Winfrey, V.P.; NagDas, S.K.; Hill, K.E.; Burk, R.F. Apolipoprotein E Receptor-2 (ApoER2) Mediates Selenium Uptake from Selenoprotein P by the Mouse Testis. J. Biol. Chem. 2007, 282, 12290-12297. [CrossRef] [PubMed]
135. Pitts, M.W.; Kremer, P.M.; Hashimoto, A.C.; Torres, D.J.; Byrns, C.N.; Williams, C.S.; Berry, M.J. Competition between the Brain and Testes under Selenium-Compromised Conditions: Insight into Sex Differences in Selenium Metabolism and Risk of Neurodevelopmental Disease. J. Neurosci. 2015, 35, 15326-15338. [CrossRef] [PubMed]
136. Davis, C.D.; Tsuji, P.A.; Milner, J.A. Selenoproteins and cancer prevention. Annu. Rev. Nutr. 2012, 32, 73-95. [CrossRef] [PubMed]
137. Behne, D.; Weiler, H.; Kyriakopoulos, A. Effects of selenium deficiency on testicular morphology and function in rats. J. Reprod. Fertil. 1996, 106, 291-297. [CrossRef] [PubMed]
138. Hill, K.E.; Zhou, J.; McMahan, W.J.; Motley, A.K.; Burk, R.F. Neurological Dysfunction Occurs in Mice with Targeted Deletion of the Selenoprotein P Gene. J. Nutr. 2004, 134, 157-161. [PubMed]